+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Aicardi Goutieres Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Aicardi Goutieres Syndrome - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 62 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 105 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 114 Pages
  • Global
From
Bullous Pemphigoid - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Bullous Pemphigoid - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Crohn's Disease (CD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Crohn's Disease (CD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Crohn's Disease (CD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Crohn's Disease (CD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Autoimmune pulmonary alveolar proteinosis (aPAP) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Autoimmune pulmonary alveolar proteinosis (aPAP) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Diffuse cutaneous systemic sclerosis (dcSSc) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Diffuse cutaneous systemic sclerosis (dcSSc) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Sanfilippo Syndrome Type A (MPS IIIA) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Sanfilippo Syndrome Type A (MPS IIIA) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Behcet's Disease - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Behcet's Disease - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Seasonal Allergic Rhinitis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Seasonal Allergic Rhinitis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Allergic Bronchopulmonary Aspergillosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Allergic Bronchopulmonary Aspergillosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Alopecia Areata - Epidemiology Forecast to 2032 - Product Thumbnail Image

Alopecia Areata - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Rhinosinusitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rhinosinusitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Seasonal Allergic Rhinitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Seasonal Allergic Rhinitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Systemic Juvenile Idiopathic Arthritis (SJIA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis (SJIA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Systemic Lupus Erythematosus - Epidemiology Forecast to 2032 - Product Thumbnail Image

Systemic Lupus Erythematosus - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Systemic Mastocytosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Systemic Mastocytosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Urticaria Therapeutics - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Urticaria Therapeutics - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Graves Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Graves Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more